Healthcare provider profile · identity verified

Richard J Kolodrubetz, MD

Family Practice · ELLICOTT CITY, MD · NPI 1619083508

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	406	103
Rosuvastatin Calcium	Rosuvastatin Calcium	290	81
Losartan Potassium	Losartan Potassium	215	61
Amlodipine Besylate	Amlodipine Besylate	162	50
Lisinopril	Lisinopril	157	45
Metoprolol Succinate	Metoprolol Succinate	154	42
Levothyroxine Sodium	Levothyroxine Sodium	134	34
Metformin Hcl	Metformin Hcl	131	33
Hydrochlorothiazide	Hydrochlorothiazide	109	28
Omeprazole	Omeprazole	98	24
Tamsulosin Hcl	Tamsulosin Hcl	95	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	89	26
Alprazolam	Alprazolam	86	21
Farxiga	Dapagliflozin Propanediol	71	16
Metformin Hcl Er	Metformin Hcl	70	24
Fluoxetine Hcl	Fluoxetine Hcl	64	17
Pravastatin Sodium	Pravastatin Sodium	59	18
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Montelukast Sodium	Montelukast Sodium	52	15
Simvastatin	Simvastatin	51	15
Synthroid	Levothyroxine Sodium	50	12
Gabapentin	Gabapentin	49	13
Glipizide Er	Glipizide	46	13
Trazodone Hcl	Trazodone Hcl	45	19
Allopurinol	Allopurinol	44	12
Ezetimibe	Ezetimibe	42	14
Fluticasone Propionate	Fluticasone Propionate	39	suppressed
Sertraline Hcl	Sertraline Hcl	39	suppressed
Eliquis	Apixaban	38	11
Zolpidem Tartrate	Zolpidem Tartrate	38	13
Tramadol Hcl	Tramadol Hcl	36	11
Atenolol	Atenolol	34	suppressed
Finasteride	Finasteride	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ozempic	Semaglutide	32	suppressed
Trulicity	Dulaglutide	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Methylprednisolone	Methylprednisolone	26	20
Clonazepam	Clonazepam	25	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Glipizide	Glipizide	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Furosemide	Furosemide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Famotidine	Famotidine	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Valsartan	Valsartan	13	suppressed
Wera	Norethindrone-Ethin. Estradiol	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Gemtesa	Vibegron	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error